Healthy Volunteers Clinical Trial
Official title:
Determination of Respiratory Muscle Endurance in Healthy Adult Individuals
NCT number | NCT05237427 |
Other study ID # | 100 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | September 1, 2020 |
Est. completion date | January 18, 2023 |
Verified date | March 2023 |
Source | Kutahya Health Sciences University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The aim of this study is to determine the reference value ranges for healthy adults of the incremental threshold load test, which evaluates respiratory muscle endurance.
Status | Completed |
Enrollment | 112 |
Est. completion date | January 18, 2023 |
Est. primary completion date | September 30, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Being between the ages of 18-35 - Not having any disease - Not exercising regularly - Not smoking Exclusion Criteria: - Having a respiratory disease - Have heart disease - Have a neuromuscular disease - Have Scoliosis - Having had thoracic surgery - Having experienced the respiratory muscle endurance protocol before |
Country | Name | City | State |
---|---|---|---|
Turkey | Kutahya Health Sciences University | Kutahya |
Lead Sponsor | Collaborator |
---|---|
Kutahya Health Sciences University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Anthropometric assessment | Body weight was assessed with a digital scale in the orthostatic position, without shoes, with minimal clothing. Height was measured with the feet parallel and adjacent to each other, the arms extended by the body, and the head in a neutral position. Correlations between inspiratory muscle endurance of the incremental threshold loading protocol and anthropometric characteristics will be shown. | 5 minute | |
Primary | Incremental threshold loading test. | A measure of endurance of inspiratory muscles. | 15 minute | |
Primary | Maximal inspiratory pressure | A measure of the strength of inspiratory muscles | 20 minute | |
Secondary | Pulmonary function test - Forced expiratory volume in 1 second (FEV1) | The forced expiratory volume in 1 second (FEV1) is the volume of air (in liters) exhaled in the first second during forced exhalation after maximal inspiration. It is lung function test that are measured during spirometry. This pulmonary function test measurements were made to confirm that the respiratory function parameters of the participants were within the normal range. . | 5 minute | |
Secondary | Pulmonary function test - Forced vital capacity (FVC) | Forced vital capacity (FVC) is lung function test that are measured during spirometry. This pulmonary function test measurement is applied to confirm that the respiratory function parameters of the participants were within the normal range. | 5 minute | |
Secondary | Maximal voluntary ventilation (MVV) | It is a test that measures inspiratory endurance. MVV is the largest amount of air that a person can inhale and then exhale during a 12- to 15-s interval with maximal voluntary effort. It is determined by spirometry measurement. | 5 minute | |
Secondary | International Physical Activity Questionnaire - Short Form | This questionnaire assesses the types of intensity of physical activity and sitting time that people do as part of their daily lives are considered to estimate total physical activity in the metabolic equivalent of task (MET)-minute/week and time spent sitting. | 5 minute |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |